Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 4
1972 2
1974 2
1975 4
1976 5
1977 7
1978 12
1979 25
1980 23
1981 19
1982 24
1983 31
1984 30
1985 32
1986 51
1987 34
1988 33
1989 21
1990 29
1991 40
1992 54
1993 37
1994 43
1995 31
1996 26
1997 29
1998 13
1999 23
2000 31
2001 26
2002 30
2003 24
2004 22
2005 19
2006 21
2007 23
2008 20
2009 17
2010 24
2011 21
2012 25
2013 17
2014 27
2015 20
2016 25
2017 30
2018 19
2019 12
2020 21
2021 26
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

1,141 results
Results by year
Filters applied: . Clear all
Page 1
Temazepam.
[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risks Hum. 1996;66:161-73. IARC Monogr Eval Carcinog Risks Hum. 1996. PMID: 9097124 Free PMC article. Review. No abstract available.
Temazepam.
[No authors listed] [No authors listed] Nurs Times. 2006 Apr 4-10;102(14):31. Nurs Times. 2006. PMID: 16617968 No abstract available.
Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
Lähteenmäki R, Neuvonen PJ, Puustinen J, Vahlberg T, Partinen M, Räihä I, Kivelä SL. Lähteenmäki R, et al. Basic Clin Pharmacol Toxicol. 2019 Mar;124(3):330-340. doi: 10.1111/bcpt.13144. Epub 2018 Dec 3. Basic Clin Pharmacol Toxicol. 2019. PMID: 30295409 Free article. Clinical Trial.
We studied perceived sleep and quality of life in 92 older (age 55-91 years) outpatients with primary insomnia before and after withdrawal from long-term use of zopiclone, zolpidem or temazepam (BZDA). BZDA was withdrawn during 1 month, during which the participants receiv …
We studied perceived sleep and quality of life in 92 older (age 55-91 years) outpatients with primary insomnia before and after withdrawal f …
Temazepam (Restoril, Sandoz Pharmaceuticals).
McElnay JC, Jones ME, Alexander B. McElnay JC, et al. Drug Intell Clin Pharm. 1982 Sep;16(9):650-6. doi: 10.1177/106002808201600902. Drug Intell Clin Pharm. 1982. PMID: 6127197 Review.
Temazepam is a benzodiazepine derivative indicated for the treatment of insomnia. ...The incidence of hangover effects from 15- and 30-mg doses is relatively low. Temazepam has no proven advantages over other benzodiazepine hypnotics. ...
Temazepam is a benzodiazepine derivative indicated for the treatment of insomnia. ...The incidence of hangover effects from 15- and 3
Temazepam abuse.
Stark C, Sykes R, Mullin P. Stark C, et al. Lancet. 1987 Oct 3;2(8562):802-3. doi: 10.1016/s0140-6736(87)92539-6. Lancet. 1987. PMID: 2889020 No abstract available.
Oral temazepam causing anxiety.
Robb ND; SAAD President's Advisory Group. Robb ND, et al. Br Dent J. 2010 Jul 24;209(2):55. doi: 10.1038/sj.bdj.2010.630. Br Dent J. 2010. PMID: 20651750 No abstract available.
Intra-arterial temazepam.
Adiseshiah M, Jones DA, Round JM. Adiseshiah M, et al. BMJ. 1992 Jun 20;304(6842):1630. doi: 10.1136/bmj.304.6842.1630-a. BMJ. 1992. PMID: 1628095 Free PMC article. No abstract available.
Misuse of temazepam.
Launchbury AP, Drake J, Seager H. Launchbury AP, et al. BMJ. 1992 Jul 25;305(6847):252-3. doi: 10.1136/bmj.305.6847.252-c. BMJ. 1992. PMID: 1392841 Free PMC article. No abstract available.
Misuse of temazepam.
Farrell M, Strang J. Farrell M, et al. BMJ. 1988 Nov 26;297(6660):1402. doi: 10.1136/bmj.297.6660.1402-a. BMJ. 1988. PMID: 2905899 Free PMC article. No abstract available.
Insomnia. Diagnosis and management.
Grunstein R. Grunstein R. Aust Fam Physician. 2002 Nov;31(11):995-1000. Aust Fam Physician. 2002. PMID: 12471955 Review.
1,141 results